+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hematologic Malignancy Drug"

Hematologic Malignancies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Thumbnail Image

Hematologic Malignancies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • November 2023
  • 148 Pages
  • Global
From
Global Hematologic Malignancies Testing Market by Product (Consumables, Services, Testing Kits), Technology (Fluorescence In Situ Hybridization, Immunohistochemistry, Next-Generation Sequencing), Disease Type, End-Users - Forecast 2024-2030 - Product Thumbnail Image

Global Hematologic Malignancies Testing Market by Product (Consumables, Services, Testing Kits), Technology (Fluorescence In Situ Hybridization, Immunohistochemistry, Next-Generation Sequencing), Disease Type, End-Users - Forecast 2024-2030

  • Report
  • March 2024
  • 184 Pages
  • Global
From
Global Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Global Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 111 Pages
  • Global
From
Global Hematologic Malignancies Testing Market: Focus on Hematologic Malignancies Testing Product and Application, Supply Chain Analysis, and Country Analysis - Analysis and Forecast, 2022-2032 - Product Thumbnail Image

Global Hematologic Malignancies Testing Market: Focus on Hematologic Malignancies Testing Product and Application, Supply Chain Analysis, and Country Analysis - Analysis and Forecast, 2022-2032

  • Report
  • June 2022
  • 278 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

The Hematologic Malignancy Drug market is a subset of the Oncology Drugs market, which focuses on the treatment of blood cancers such as leukemia, lymphoma, and myeloma. These drugs are used to treat both acute and chronic forms of these diseases, and can be administered orally, intravenously, or subcutaneously. Common drugs used in this market include chemotherapy, targeted therapy, immunotherapy, and stem cell transplantation. The Hematologic Malignancy Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in this market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more